Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System
-
Published:2020
Issue:4
Volume:46
Page:e20180255-e20180255
-
ISSN:1806-3756
-
Container-title:Jornal Brasileiro de Pneumologia
-
language:
-
Short-container-title:J Bras Pneumol.
Author:
Aguiar Jr1 PedroORCID,
Roitberg FelipeORCID,
Lopes Jr GilbertoORCID,
Giglio Auro delORCID
Publisher
Sociedade Brasileira de Pneumologia e Tisiologia